Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-028661
Filing Date
2024-12-09
Accepted
2024-12-09 16:52:50
Documents
1
Period of Report
2024-12-05

Document Format Files

Seq Description Document Type Size
1 form4-12092024_091246.html 4  
1 form4-12092024_091246.xml 4 7517
  Complete submission text file 0001415889-24-028661.txt   8980
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address
TANG KEVIN (Reporting) CIK: 0001178579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36421 | Film No.: 241535764

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)